About Swiss Parenterals
Swiss Parenterals is a company based in Ahmedabad (India) founded in 1986 by Vikrambhai Rasiklal Shah was acquired by ERIs Life Sciences in February 2024. It operates as a Direct-to-Consumer (D2C), and Reseller / Distribution. Swiss Parenterals offers products and services including Sterile Injectables, Oral Solids, Semi-Solids, Nutritional Supplements, and Ayurvedic Products. Swiss Parenterals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Ahmedabad, India
- Founders Vikrambhai Rasiklal Shah
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Swiss Parenterals
-
Annual Revenue
$38.52 M (USD)36as on Mar 31, 2024
-
Net Profit
$8.45 M (USD)18as on Mar 31, 2024
-
EBITDA
$12.87 M (USD)20as on Mar 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
ERIs Life Sciences
(Feb 13, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Swiss Parenterals
Swiss Parenterals offers a comprehensive portfolio of products and services, including Sterile Injectables, Oral Solids, Semi-Solids, Nutritional Supplements, and Ayurvedic Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Sterile injectables are manufactured for global market distribution.
Oral solids are produced for various health condition treatments.
Semi-solids are optimized for controlled injection in treatments.
Nutritional supplements are offered to boost immunity and energy.
Ayurvedic products are developed for physical and mental health.
Unlock access to complete
Funding Insights of Swiss Parenterals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Swiss Parenterals
Swiss Parenterals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ERIs Life Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical formulations for chronic diseases are manufactured and studied.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Swiss Parenterals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Swiss Parenterals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Swiss Parenterals Comparisons
Competitors of Swiss Parenterals
Swiss Parenterals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Swiss Parenterals
Frequently Asked Questions about Swiss Parenterals
When was Swiss Parenterals founded?
Swiss Parenterals was founded in 1986.
Where is Swiss Parenterals located?
Swiss Parenterals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Who is the current CEO of Swiss Parenterals?
Piyush Pandya is the current CEO of Swiss Parenterals.
What is the annual revenue of Swiss Parenterals?
Annual revenue of Swiss Parenterals is $38.52M as on Mar 31, 2024.
What does Swiss Parenterals do?
Swiss Parenterals is involved in the development and manufacturing of sterile injectables, oral solids, semi-solids, and nutritional supplements for global markets. The company operates in over 80 countries, focusing on generic and specialty pharmaceuticals. Its services include product development, analytical support, and regulatory assistance at cGMP-compliant facilities. Approvals from EU-GMP, Brazilian ANVISA, and other international bodies are held by the company. A wide range of dosage forms, including complex formulations, are produced across three manufacturing units in Ahmedabad, India. Veterinary and Ayurvedic products are also offered to cater to diverse health needs.
Who are the top competitors of Swiss Parenterals?
Swiss Parenterals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
What products or services does Swiss Parenterals offer?
Swiss Parenterals offers Sterile Injectables, Oral Solids, Semi-Solids, Nutritional Supplements, and Ayurvedic Products.
Who are Swiss Parenterals's investors?
Swiss Parenterals has 1 investor. Key investors include ERIs Life Sciences.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.